Vote Scores

Home / Companies / Ambrx Biopharma, Inc. / 10 Oct 2023

Meeting · year to 30 June 202420 filers reporting

Ambrx Biopharma, Inc.: meeting of 10 Oct 2023

Votes reported on Form N-PX, item by item

20 Form N-PX filers reported votes at the Ambrx Biopharma, Inc. meeting of 10 Oct 2023. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

SHAREHOLDER RIGHTS AND DEFENSESIssuer

SHAREHOLDER RIGHTS AND DEFENSES: management items

Management items in this category are shown together; filers word and number them differently.

67 vote records from 20 filers. 10 of the 20 filers that marked the item either way voted against management.

45.0% for50.0% against5.0% other50.0% against management20 filers39.3% for60.7% against60.7% against management14,524,765 reported shares, counted once per item in this group
2

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

19 vote records from 16 filers. 0 of the 16 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management16 filers100.0% for0.0% against0.0% against management4,816,289 reported shares, counted once per item in this group
3

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

24 vote records from 20 filers. 6 of the 20 filers that marked the item either way voted against management.

70.0% for30.0% against30.0% against management20 filers57.8% for42.2% against42.2% against management4,854,238 reported shares, counted once per item in this group
4

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

82 vote records from 20 filers. 6 of the 20 filers that marked the item either way voted against management.

70.0% for30.0% against30.0% against management20 filers74.4% for25.6% against25.6% against management14,638,612 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Ambrx Biopharma, Inc. meeting?

20 Form N-PX filers reported votes at the meeting of 10 Oct 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Ambrx Biopharma, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Ambrx Biopharma, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Ambrx Biopharma, Inc. with a meeting date within three days of 10 Oct 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.